Outset Medical (OM) EBITDA Margin Growth (5y) (2024 - 2026)
Outset Medical (OM) EBITDA Margin Growth (5y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.82 Bn | 196.22 Bn | 7.27 Bn |
| 2 | Stryker | 127.00 Bn | 123.52 Bn | 4.50 Bn |
| 3 | Medtronic | 118.94 Bn | 109.72 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.26 Bn | 73.72 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.61 Bn | 47.36 Bn | 1.35 Bn |
| 6 | Dexcom | 35.00 Bn | 33.05 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.71 Bn | 31.60 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn |
| 9 | Steris | 23.16 Bn | 22.68 Bn | 684.20 Mn |
| 10 | Outset Medical | 80.34 Mn | -182.85 Mn | 13.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6,905.00 |
| Mar 31, 2026 | 6,878.00 |
| Dec 31, 2025 | 12,225.00 |
| Sep 30, 2025 | 24,238.00 |
| Jun 30, 2025 | 15,846.00 |
| Mar 31, 2025 | 22,597.00 |
| Dec 31, 2024 | 18,792.00 |
| Sep 30, 2024 | 61,836.00 |